![](https://phagetherapy-site.com/wp-content/uploads/2025/02/Practical-Phage-Session-jpg.avif)
A Practical Guide Covering Technical, Regulatory, and Business Aspects
Targeting Phage Therapy 2025 is dedicating a practical session to “How to Produce, Manufacture, and Bring Phage Products to Market”. This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.
Key Topics Covered:
Technical & Manufacturing Aspects
- Good Manufacturing Practices (GMP) for Phage Production – Ensuring compliance with pharmaceutical and industrial regulations
- Scaling Production: Challenges and solutions in large-scale phage manufacturing
- Quality Control & Standardization: Developing consistent, safe, and effective phage-based products
Regulatory & Administrative Aspects
- Regulatory Pathways for Phage Products – Understanding approval processes for therapeutic, veterinary, and industrial applications
- Documentation & Compliance – Key administrative requirements for licensing and product registration
- How to Import Phage Products into Europe – Navigating regulations for importing phages that are available as OTC (over-the-counter) treatments in other countries
- Who Controls Phage Banks in Europe and Internationally? – Overview of institutions, regulatory bodies, and guidelines governing the collection, storage, and distribution of bacteriophage strains
Business & Market Strategy
- Market Access & Commercialization Strategies – How to bring phage products to clinical, veterinary, and food industries
- Investment & Funding Opportunities – Navigating financial aspects for startups and biotech companies
Interactive Q&A
This session will answer all practical and administrative questions related to phage production, commercialization, regulation, and international importation, ensuring that researchers, startups, and industry leaders have the tools needed to successfully bring phage-based solutions to market.